RESULTS
wart, itching, swelling, periungual warts, dyspigmentation, left third periungual
PLANTAR WARTS, WART, COMMON WARTS, PERIUNGUAL WARTS, WARTS, WARTS, FILIFORM WART, FILIFORM WART, PLANTAR WART
The average age of the 40 patients in this study was 12.8‐20.1 (range: 20 months–52years) old, whereas the median age was 18, and the interquartile range was 10–27. There were 1.86 times as many women as there were men involved in the cases. Warts often lasted anywhere from 4 months to 3 years on average (Table Demographic characteristics of 40 patients with cutaneous warts.Abrreviation: SD, standard deviation.Pie‐chart showing the gender distribution and male to female ratio of 40 patients with cutaneous warts.Frequency distribution of a number of cutaneous warts among the studied groupaTotal number of lesions =204.The majority (146/71.6%) of the 204 warts were common warts; other forms included plantar warts (23%), periungual warts (9%), and a single filiform wart (0.5%) (Table Frequency distribution of types of warts (Proportional distribution of 204 warts of the 40 patients with cutaneous warts.The mean size of the 204 warts was reduced from 6.4 mm at the beginning of therapy to 3.9 mm by the end of treatment, a decrease that was statistically significant (P0.001). The trend of the reduction in mean size at succeeding sessions is shown in Figure Box‐plot showing the change in mean wart size across subsequent treatment sessions. A highly significant reduction in mean size was found (Overall responses to treatment of 204 warts.Cumulative frequency and rates of complete response to treatment for 204 cutaneous warts at subsequent sessions of treatment.Using cross‐tabulation, we compared patients whose warts were smaller than 5 mm in diameter to those whose warts were larger than 5 mm in diameter; we found no statistically significant correlation between wart size and treatment outcome (Cross‐tabulation for the relationship between size of wart and response to treatment for 204 cutaneous warts of 40 patients.Comparison of mean size of warts across the response to treatment.Cross‐tabulation for the relationship between type of wart and response to treatment for 204 cutaneous warts of 40 patients.Filiform wart was excluded from the comparison.Comparison of mean duration of warts across the response to treatment.A boy of 20 years old with single plantar wart in left foot for 10 months shows a complete clearance of wart: (a) before treatment, (b) 2 months after four treatment sessions.A girl of 9 years old with single wart in left third periungual for 1 year shows complete clearance: (a) before treatment, (b) 1 month after two treatment sessions.A girl of 20 years old with multiple common warts in hand shows complete response: (a) before treatment, (b) 6 weeks after three treatment sessions.Women 38 years old with multiple warts in left dorsal foot show complete clearance: (a) before treatment, (b) 2 months after four treatment sessions.Bivariate Pearson's and Spearman's correlation tests were employed to investigate the relationship among age, gender, number of warts, and length of warts and response to therapy, and both tests found no significant association between these factors (Results of bivariate correlation analysis for the response to treatment and each of age, gender, number, and duration of warts for 40 patients with cutaneous warts.Pearson's correlation test used for age, number, and duration of warts, whereas Spearman's correlation test used for gender versus response rates.Minor side effects, none of which were life‐threatening, were experienced by 13 patients. Seven (53.8%) patients experienced injection‐site swelling, which went down on its own within a week. Five (38.5%) patients experienced itching, and one (7.7%) patient experienced dyspigmentation, which went away on their own after 3 weeks (Table Frequency of side effects of intralesional vitamin D3 treatment for cutaneous warts.